The Discounted Cash Flow (DCF) valuation of Charles River Laboratories International Inc (CRL) is 174.60 USD. With the latest stock price at 140.97 USD, the upside of Charles River Laboratories International Inc based on DCF is 23.9%.
Based on the latest price of 140.97 USD and our DCF valuation, Charles River Laboratories International Inc (CRL) is a buy. buying CRL stocks now will result in a potential gain of 23.9%.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 8.3% | 7.3% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 116.55 - 305.55 | 174.60 |
| Upside | -17.3% - 116.7% | 23.9% |